APOE and Alzheimer disease: Despite our increased understanding of the detrimental effect of APOE-ε4, there is also sufficient evidence of a protective effect of APOE-ε2 against AD [127, 138]; therefore, it is reasonable to consider that APOE-ε2 based therapies may yield significant therapeutic effects in APOE-ε4 and APOE-ε3 individuals.